Much research on ADHD focuses on the ways that it impairs functioning. A new study, however, illuminates how it may serve as ...

Are rising ADHD diagnoses a cultural trend, a misunderstanding, or evidence of a real neurodevelopmental difference? This ...

(RTTNews) - Johnson & Johnson (JNJ) on Thursday announced that the U.S. Food and Drug Administration (FDA) has approved Caplyta as an add-on therapy with antidepressants for the treatment of major ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...

Seasonal affective disorder (SAD) is a form of depression that occurs in the darker, colder months of the year. Individuals with ADHD may be more likely to experience this condition. If you have ...

Among patients with attention deficit-hyperactivity disorder (ADHD), the risk for psychosis was 57% higher in those treated with amphetamines versus those treated with methylphenidate, a systematic ...

“Food is my heroin,” said Haley (a pseudonym), 28, comparing her ADHD and binge eating disorder to a drug problem. “It sounds dramatic but it’s true. As hard as I try to prevent binge it’s like ...

A new study published in The Journal of Sex Research suggests that women with symptoms of attention-deficit/hyperactivity disorder (ADHD)—especially the inattentive ...

Background: The close association of syndromes of orthostatic intolerance with and without postural orthostatic tachycardia syndrome (POTS) with Joint Hypermobility Disorders (JHD) including ...

Have We Been Thinking About A.D.H.D. All Wrong? With diagnoses at a record high, some experts have begun to question our assumptions about the condition — and how to treat it. Supported by With ...